Literature DB >> 31152157

Microdeletion of pseudogene chr14.232.a affects LRFN5 expression in cells of a patient with autism spectrum disorder.

Gerarda Cappuccio1,2, Sergio Attanasio2, Marianna Alagia1, Margherita Mutarelli2, Roberta Borzone2, Marianthi Karali2,3, Rita Genesio4, Angela Mormile4, Lucio Nitsch4, Floriana Imperati1, Annalisa Esposito1, Sandro Banfi2,3, Ennio Del Giudice1, Nicola Brunetti-Pierri5,6.   

Abstract

We identified a 14q21.2 microdeletion in a 16-year-old boy with autism spectrum disorder (ASD), IQ in the lower part of normal range but high-functioning memory skills. The deletion affects a gene desert, and the non-deleted gene closest to the microdeletion boundaries is LRFN5, which encodes a protein involved in synaptic plasticity and implicated in neuro-psychiatric disorders. LRFN5 expression was significantly decreased in the proband's skin fibroblasts. The deleted region includes the pseudogene chr14.232.a, which is transcribed into a long non-coding RNA (lncLRFN5-10), whose levels were also significantly reduced in the proband's fibroblasts compared to controls. Transfection of the patient's fibroblasts with a plasmid expressing chr14.232.a significantly increased LRFN5 expression, while siRNA targeting chr14.232.a-derived lncLRFN5-10 reduced LRFN5 levels. In summary, we report on an individual with ASD carrying a microdeletion encompassing the pseudogene chr14.232.a encoding for lncLRFN5-10, which was found to affect the expression levels of the nearby, non-deleted LRFN5. This case illustrates the potential role of long non-coding RNAs in regulating expression of neighbouring genes with a functional role in ASD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31152157      PMCID: PMC6777536          DOI: 10.1038/s41431-019-0430-5

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

Review 1.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 2.  Triple X syndrome: a review of the literature.

Authors:  Maarten Otter; Constance T R M Schrander-Stumpel; Leopold M G Curfs
Journal:  Eur J Hum Genet       Date:  2009-07-01       Impact factor: 4.246

3.  A candidate gene association study further corroborates involvement of contactin genes in autism.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2014-05-17

Review 4.  Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function.

Authors:  J L Knauss; T Sun
Journal:  Neuroscience       Date:  2013-01-18       Impact factor: 3.590

5.  An update on LNCipedia: a database for annotated human lncRNA sequences.

Authors:  P J Volders; K Verheggen; G Menschaert; K Vandepoele; L Martens; J Vandesompele; P Mestdagh
Journal:  Nucleic Acids Res       Date:  2015-03-31       Impact factor: 16.971

6.  Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.

Authors:  Lucilla Pizzo; Matthew Jensen; Andrew Polyak; Jill A Rosenfeld; Katrin Mannik; Arjun Krishnan; Elizabeth McCready; Olivier Pichon; Cedric Le Caignec; Anke Van Dijck; Kate Pope; Els Voorhoeve; Jieun Yoon; Paweł Stankiewicz; Sau Wai Cheung; Damian Pazuchanics; Emily Huber; Vijay Kumar; Rachel L Kember; Francesca Mari; Aurora Curró; Lucia Castiglia; Ornella Galesi; Emanuela Avola; Teresa Mattina; Marco Fichera; Luana Mandarà; Marie Vincent; Mathilde Nizon; Sandra Mercier; Claire Bénéteau; Sophie Blesson; Dominique Martin-Coignard; Anne-Laure Mosca-Boidron; Jean-Hubert Caberg; Maja Bucan; Susan Zeesman; Małgorzata J M Nowaczyk; Mathilde Lefebvre; Laurence Faivre; Patrick Callier; Cindy Skinner; Boris Keren; Charles Perrine; Paolo Prontera; Nathalie Marle; Alessandra Renieri; Alexandre Reymond; R Frank Kooy; Bertrand Isidor; Charles Schwartz; Corrado Romano; Erik Sistermans; David J Amor; Joris Andrieux; Santhosh Girirajan
Journal:  Genet Med       Date:  2018-09-07       Impact factor: 8.822

7.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs).

Authors:  Dan E Arking; Daniel B Campbell; Heather C Mefford; Eric M Morrow; Lauren A Weiss; Brett S Abrahams; Idan Menashe; Tim Wadkins; Sharmila Banerjee-Basu; Alan Packer
Journal:  Mol Autism       Date:  2013-10-03       Impact factor: 7.509

8.  SALM5 trans-synaptically interacts with LAR-RPTPs in a splicing-dependent manner to regulate synapse development.

Authors:  Yeonsoo Choi; Jungyong Nam; Daniel J Whitcomb; Yoo Sung Song; Doyoun Kim; Sangmin Jeon; Ji Won Um; Seong-Gyu Lee; Jooyeon Woo; Seok-Kyu Kwon; Yan Li; Won Mah; Ho Min Kim; Jaewon Ko; Kwangwook Cho; Eunjoon Kim
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

9.  Structural basis of SALM5-induced PTPδ dimerization for synaptic differentiation.

Authors:  Zhaohan Lin; Jianmei Liu; Huandi Ding; Fei Xu; Heli Liu
Journal:  Nat Commun       Date:  2018-01-18       Impact factor: 14.919

10.  Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases.

Authors:  Kelly D Farwell Hagman; Deepali N Shinde; Cameron Mroske; Erica Smith; Kelly Radtke; Layla Shahmirzadi; Dima El-Khechen; Zöe Powis; Elizabeth C Chao; Wendy A Alcaraz; Katherine L Helbig; Samin A Sajan; Mari Rossi; Hsiao-Mei Lu; Robert Huether; Shuwei Li; Sitao Wu; Mark E Nuñes; Sha Tang
Journal:  Genet Med       Date:  2016-08-11       Impact factor: 8.822

View more
  6 in total

1.  LRFN5 locus structure is associated with autism and influenced by the sex of the individual and locus conversions.

Authors:  Helle Lybaek; Michael Robson; Nicole de Leeuw; Jayne Y Hehir-Kwa; Aaron Jeffries; Bjørn Ivar Haukanes; Siren Berland; Diederik de Bruijn; Stefan Mundlos; Malte Spielmann; Gunnar Houge
Journal:  Autism Res       Date:  2022-01-28       Impact factor: 4.633

2.  Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.

Authors:  Adam D Ewing; Seth W Cheetham; James J McGill; Michael Sharkey; Rick Walker; Jennifer A West; Malcolm J West; Kim M Summers
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

Review 3.  Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics.

Authors:  Amanda M Buch; Conor Liston
Journal:  Neuropsychopharmacology       Date:  2020-08-11       Impact factor: 8.294

4.  Identification of a robust non-coding RNA signature in diagnosing autism spectrum disorder by cross-validation of microarray data from peripheral blood samples.

Authors:  Wei Cheng; Shanhu Zhou; Jinxia Zhou; Xijia Wang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

Review 5.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 6.  Interpreting the impact of noncoding structural variation in neurodevelopmental disorders.

Authors:  Eva D'haene; Sarah Vergult
Journal:  Genet Med       Date:  2020-09-25       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.